Εμφάνιση απλής εγγραφής

dc.creatorChantzara E., Xenidis N., Kallergi G., Georgoulias V., Kotsakis A.en
dc.date.accessioned2023-01-31T07:42:58Z
dc.date.available2023-01-31T07:42:58Z
dc.date.issued2021
dc.identifier10.1080/14737159.2021.1962710
dc.identifier.issn14737159
dc.identifier.urihttp://hdl.handle.net/11615/72493
dc.description.abstractIntroduction : Despite advances in diagnostic and therapeutic techniques breast cancer is still associated with significant morbidity and mortality. CTCs play a crucial role in the metastatic process, which is the main cause of death in BC patients. Areas covered : This review discusses the prognostic and predictive value of CTCs and their prospective in management of BC patients. Expert opinion : The analysis of CTCs through improved technologies offers a new insight into the metastatic cascade. Assessment of the number and molecular profile of CTCs holds great promises for disease monitoring and therapeutic decisions. However, more research is needed until they can be used in therapeutic decisions in clinical practice. © 2021 Informa UK Limited, trading as Taylor & Francis Group.en
dc.language.isoenen
dc.sourceExpert Review of Molecular Diagnosticsen
dc.source.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85112088203&doi=10.1080%2f14737159.2021.1962710&partnerID=40&md5=6557a41119ca01bdd40fc65346eae19c
dc.subjectantineoplastic agenten
dc.subjecttumor markeren
dc.subjecttumor markeren
dc.subjectadjuvant chemotherapyen
dc.subjectadjuvant therapyen
dc.subjectbreast canceren
dc.subjectcancer hormone therapyen
dc.subjectcancer patienten
dc.subjectcancer prognosisen
dc.subjectcirculating tumor cellen
dc.subjectclinical decision makingen
dc.subjectclinical practiceen
dc.subjecthumanen
dc.subjectmetastasisen
dc.subjectmonitoringen
dc.subjectmorbidityen
dc.subjectpostoperative careen
dc.subjectpredictive valueen
dc.subjectReviewen
dc.subjectvalidityen
dc.subjectbreast tumoren
dc.subjectfemaleen
dc.subjectpathologyen
dc.subjectprognosisen
dc.subjectprospective studyen
dc.subjecttumor embolismen
dc.subjectBiomarkers, Tumoren
dc.subjectBreast Neoplasmsen
dc.subjectFemaleen
dc.subjectHumansen
dc.subjectNeoplastic Cells, Circulatingen
dc.subjectPrognosisen
dc.subjectProspective Studiesen
dc.subjectTaylor and Francis Ltd.en
dc.titleCirculating tumor cells as prognostic biomarkers in breast cancer: current status and future prospectsen
dc.typeotheren


Αρχεία σε αυτό το τεκμήριο

ΑρχείαΜέγεθοςΤύποςΠροβολή

Δεν υπάρχουν αρχεία που να σχετίζονται με αυτό το τεκμήριο.

Αυτό το τεκμήριο εμφανίζεται στις ακόλουθες συλλογές

Εμφάνιση απλής εγγραφής